Monday, 13 January 2014

Synergising Research into ME


Welcome to IIMEC9 - the 9th Invest in ME International ME Conference 2014 in Westminster, London, UK, on 30th May 2014.

Today Invest in ME announce some of the speakers at the 2014 conference.

The key to resolving, treating and curing ME lies in biomedical research.

Healthcare staff need to be aware of the latest biomedical research into ME as well as the multiple symptoms exhibited by ME patients and of the possible treatments available and future research directions.


Benefits of attending Invest in ME 2014 Conference

o   Increase your understanding of diagnosis, treatment and management of ME

o   Explore current and future biomedical research into ME

o   Assess the role of immunological markers in ME

o   Learn about ongoing clinical trials using Rituximab to treat ME patients

o   Learn about inflammation in the CNS and its contribution to neurological disease

o   Learn about the function of the immune response in the gut

o   Share and exchange ideas with the leading practitioners in the field


Who should attend?

IIMEC9 will be of interest to:

o Specialists in ME (CFS)

o GPs with an interest in ME (CFS)

o Neurologists

o Immunologists

o Virologists

o Palliative care nurses

o Occupational Therapists

o Specialists in pain management

o Specialists in care of the chronically ill

o Community nurses

o All trainees in these disciplines

o ME Support groups and charities


Conference fee includes:

Entrance to the conference, lunch & refreshments, full conference documentation and certificate of accreditation (for professionals).


Confirmed Speakers:

Invest in ME are pleased to announce the following speakers at the conference -  

Professor Jonathan Edwards
  Emeritus Professor of Connective Tissue Medicine University College London (UCL), UK

Associate Professor Mady Hornig
  Center for Infection and Immunity (CII), Columbia University Mailman School of Public Health New York, USA

Professor Sonya Marshall-Gradisnik
  Associate Professor, Biochemistry, Griffith University, Australia

Professor Julia Newton
  Clinical Professor of Ageing and Medicine, Institute for Ageing and Health, Newcastle University and Honorary Consultant Physician, Royal Victoria Infirmary, UK

Dr James Baraniuk
  Professor of Medicine at Georgetown University Medical Centre, USA

Dr Ian Gibson 
  Former Dean of Biological Sciences, University of East Anglia

Additional speakers are expected to be announced shortly

The conference follows the Invest in ME Biomedical Researchinto ME 4 seminar which covers the major initiatives in ME research being performed and in which these speakers will also participate.

As the Invest in ME initiated and funded research becomes underway at UEA (gut microbiome) and UCL (rituximab clinical trial) the conference will reflect the research being performed and focus on synergizing the research elements from around the world to find cause and provide treatments for this disease.

Also present at the conference will be representatives of the European ME Alliance (EMEA) as the EMEA AGM takes place after the conference.

CPD Accreditation from the Royal colleges has been applied for and we hope to obtain the maximum credits for the conference, as in previous years.

How can we ensure ME research and patient care benefit from the latest thinking in ME/CFS and related areas of research?  What is the best way forward?

The Invest in ME conferences have attracted presenters and delegates from fifteen countries and our DVDs of the conferences have been distributed to over 20 countries in Europe, USA, Canada, Australia and New Zealand.

Conference Registration:

Full details of the conference can be found at this address - click here.

IiME are again offering a discounted rate for healthcare staff who attend in connection with a local ME Support Group. IiME welcome all professionals who are working with, or have an interest in, ME/CFS.

Should you have any further questions relating to the conference please contact us at 

We look forward to welcoming you to the conference,

Invest in ME

No comments: